Jie Jiang

4.4k total citations · 1 hit paper
80 papers, 3.2k citations indexed

About

Jie Jiang is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Jie Jiang has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 16 papers in Hematology and 14 papers in Genetics. Recurrent topics in Jie Jiang's work include Protein Degradation and Inhibitors (17 papers), Hemoglobinopathies and Related Disorders (9 papers) and Ubiquitin and proteasome pathways (8 papers). Jie Jiang is often cited by papers focused on Protein Degradation and Inhibitors (17 papers), Hemoglobinopathies and Related Disorders (9 papers) and Ubiquitin and proteasome pathways (8 papers). Jie Jiang collaborates with scholars based in United States, China and United Kingdom. Jie Jiang's co-authors include Swee Lay Thein, Steve Best, Nicholas Silver, Stephan Menzel, Tim D. Spector, Nathanael S. Gray, Qiang Zhou, Michael Levine, Haini N. Cai and Tinghu Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Jie Jiang

71 papers receiving 3.2k citations

Hit Papers

Selection of housekeeping genes for gene expression studi... 2006 2026 2012 2019 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR
    2006 1.4k citations Nicholas Silver, Steve Best et al. profile →

Peers

Jie Jiang
Gang Wu United States
Yong‐Dong Wang United States
Martin Granzow Germany
Shih-Feng Tsai Taiwan
Michela Mattioli Italy
Zhu Chen China
Weijun Luo United States
Jonathan LaMarre Canada
Pudur Jagadeeswaran United States
Melissa L. Holmes Australia
Gang Wu United States
Jie Jiang
Citations per year, relative to Jie Jiang Jie Jiang (= 1×) peers Gang Wu

Countries citing papers authored by Jie Jiang

Since Specialization
Citations

This map shows the geographic impact of Jie Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Jiang more than expected).

Fields of papers citing papers by Jie Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Jiang. The network helps show where Jie Jiang may publish in the future.

Co-authorship network of co-authors of Jie Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Jiang. A scholar is included among the top collaborators of Jie Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Jiang. Jie Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gui, Fu, Baishan Jiang, Jie Jiang, et al.. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances. 11(17). eadu0847–eadu0847. 2 indexed citations
3.
Zhao, Hongbo, et al.. (2024). Biochemical analysis of EGFR exon20 insertion variants insASV and insSVD and their inhibitor sensitivity. Proceedings of the National Academy of Sciences. 121(45). e2417144121–e2417144121. 1 indexed citations
4.
Du, Guangyan, Jie Jiang, Wenchao Lu, et al.. (2024). Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). European Journal of Medicinal Chemistry. 276. 116613–116613. 1 indexed citations
5.
Dai, Wei, Xieyuanli Chen, Meiping Wu, et al.. (2024). Efficient and Precise Homo-Hetero Teleoperation Based on an Optimized Upper Limb Exoskeleton. IEEE/ASME Transactions on Mechatronics. 30(5). 3722–3734. 2 indexed citations
6.
Li, Zhengnian, Jie Jiang, Scott B. Ficarro, et al.. (2024). Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality. ACS Central Science. 10(6). 1156–1166. 5 indexed citations
7.
Zhu, Youming, et al.. (2024). Clinical Characteristics of Lung Abscess Caused by Streptococcus Constellatus Infection. Clinical Laboratory. 70(07/2024). 1 indexed citations
8.
Li, Zhengnian, Wenchao Lu, Tyler S. Beyett, et al.. (2024). ZNL0325, a Pyrazolopyrimidine-Based Covalent Probe, Demonstrates an Alternative Binding Mode for Kinases. Journal of Medicinal Chemistry. 67(4). 2837–2848. 2 indexed citations
9.
Wang, Ling, Jie Wei, Qinghuan Zhang, et al.. (2024). Whole-Genome Sequencing of an Escherichia coli ST69 Strain Harboring blaCTX-M-27 on a Hybrid Plasmid. Infection and Drug Resistance. Volume 17. 365–375. 3 indexed citations
10.
Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie. 135(18).
11.
Eck, Michael J., David A. Scott, Pasi A. Jänne, et al.. (2023). Abstract LB_C14: EAI-432: A mutant-selective allosteric EGFR inhibitor for L858R-mutant non-small cell lung cancer. Molecular Cancer Therapeutics. 22(12_Supplement). LB_C14–LB_C14. 2 indexed citations
12.
Jiang, Baishan, Yang Gao, Jianwei Che, et al.. (2021). Discovery and resistance mechanism of a selective CDK12 degrader. Nature Chemical Biology. 17(6). 675–683. 96 indexed citations
13.
Ryu, SeongShick, Benjamin Fram, Jie Jiang, et al.. (2021). Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9. SHILAP Revista de lepidopterología. 1. 100008–100008. 2 indexed citations
14.
Jiang, Jie, Hong Cai, Jie Qu, & Chunhui Yang. (2020). [Costunolide Suppresses Proliferation of K562 Cells through JAK/STAT Signaling Pathway].. PubMed. 28(2). 460–463. 1 indexed citations
15.
Bono, Elisa, Donal P. McLornan, Erica Travaglino, et al.. (2017). Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization. Blood. 130. 588–588. 1 indexed citations
16.
Smith, Alexander, Austin Kulasekararaj, Jie Jiang, et al.. (2015). CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis. The Lancet Haematology. 2(5). e212–e221. 13 indexed citations
17.
Kulasekararaj, Austin, Jie Jiang, Alexander Smith, et al.. (2014). Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 124(17). 2698–2704. 168 indexed citations
18.
Jiang, Jie, Daryl Cole, Nigel Westwood, et al.. (2010). Crucial Roles for Protein Kinase C Isoforms in Tumor-Specific Killing by Apoptin. Cancer Research. 70(18). 7242–7252. 27 indexed citations
19.
Jiang, Jie & James D. Griffin. (2010). Wnt/ -catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3  Dependent Manner. Genes & Cancer. 1(2). 164–176. 12 indexed citations
20.
Lai, Mei I, Jie Jiang, Nicholas Silver, et al.. (2006). α‐Haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of β‐thalassaemia. British Journal of Haematology. 133(6). 675–682. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gang Wu Breakdown of academic impact, for papers by Yong‐Dong Wang Breakdown of academic impact, for papers by Martin Granzow Breakdown of academic impact, for papers by Shih-Feng Tsai Breakdown of academic impact, for papers by Michela Mattioli Breakdown of academic impact, for papers by Zhu Chen Breakdown of academic impact, for papers by Weijun Luo Breakdown of academic impact, for papers by Jonathan LaMarre Breakdown of academic impact, for papers by Pudur Jagadeeswaran Breakdown of academic impact, for papers by Melissa L. Holmes
Rankless by CCL
2026